We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
APLLTD.NSE

Price
846.40
Stock movement up
+6.10 (0.73%)
Company name
Alembic Pharmaceuticals Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
166.37B
Ent value
188.58B
Price/Sales
2.62
Price/Book
3.40
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
25.72
Forward P/E
23.23
PEG
-
EPS growth
0.21%
1 year return
-15.79%
3 year return
3.58%
5 year return
9.53%
10 year return
7.66%
Last updated: 2025-04-12

DIVIDENDS

APLLTD.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E25.72
Price to OCF119.78
Price to FCF119.78
Price to EBITDA61.80
EV to EBITDA70.05

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales2.62
Price to Book3.40
EV to Sales2.97

FINANCIALS

Per share

Per share data
Current share count196.56M
EPS (TTM)32.84
FCF per share (TTM)7.05

Income statement

Income statement data
Revenue (TTM)63.57B
Gross profit (TTM)37.74B
Operating income (TTM)7.27B
Net income (TTM)6.47B
EPS (TTM)32.84
EPS (1y forward)36.43

Margins

Margins data
Gross margin (TTM)59.36%
Operating margin (TTM)11.43%
Profit margin (TTM)10.17%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.22B
Net receivables0.00
Total current assets37.62B
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets72.30B
Accounts payable8.89B
Short/Current long term debt10.66B
Total current liabilities21.72B
Total liabilities23.43B
Shareholder's equity48.88B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.39B
Capital expenditures (TTM)0.00
Free cash flow (TTM)1.39B
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity13.23%
Return on Assets8.95%
Return on Invested Capital10.96%
Cash Return on Invested Capital2.35%

STOCK INFORMATION

Stock chart

Stock price data
Open848.00
Daily high865.15
Daily low836.05
Daily Volume175K
All-time high1247.70
1y analyst estimate1138.42
Beta0.69
EPS (TTM)32.84
Dividend per share-
Ex-div date15 Jul 2024
Next earnings date7 May 2025

Downside potential

Downside potential data
APLLTD.NSES&P500
Current price drop from All-time high-32.16%-12.89%
Highest price drop-58.41%-56.47%
Date of highest drop29 Mar 20239 Mar 2009
Avg drop from high-20.39%-11.07%
Avg time to new high23 days12 days
Max time to new high1178 days1805 days
COMPANY DETAILS
APLLTD.NSE (Alembic Pharmaceuticals Limited) company logo
Marketcap
166.37B
Marketcap category
Large-cap
Description
Alembic Pharmaceuticals Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company provides branded specialty medicines in various therapeutic areas, such as cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. The company was founded in 1907 and is headquartered in Vadodara, India.
Employees
14858
Website
https://alembicpharmaceuticals.com
Investor relations
-
SEC filings
APLLTD.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved